Compare Aurora Cannabis Inc (ACB) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

MSTU trades at $2.15, unchanged on the day, with a bearish technical outlook indicated by moving averages and ADX signals. The ETF has experienced extreme volatility, with news reports highlighting a 95% annual decline. Key support and resistance are at $2 and $3, respectively. Financial ratios are unavailable, and the fund's performance is directly tied to the daily moves of its underlying asset.

The outlook for MSTU is highly speculative and carries significant risk due to its leveraged structure, which can amplify losses. Investor sentiment is negative following substantial historical declines. Any investment is a high-risk bet on short-term price movements of the underlying asset, not a long-term fundamental holding.